CRISPR/Cas9 technology generated a GCA to GTT change resulting in an alanine to valine substitution at residue 340 (A340V). This mutation is common in long QT syndrome 1 patients. (J:322020)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count